Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018

. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.
Reference: 1409177
Price: $1,800.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
Sept. 2014
Pages
50
Version:
2014
Charts:
30
Language
  • English
  • Chinese
Format
License

Description

China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly-pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1) in six manufacturers of biological products. Porcine reproductive and respiratory syndrome (PRRS) remains one of the key compulsory immunity diseases in China.

According to National Compulsory Immunization Plan of Animal Epidemic Diseases in 2014 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly-pathogenic PRRS. The government is responsible for the expenses. Currently highly pathogenic PRRS vaccines are purchased by the government through invitation for bidding in China.

The market competition is intensive in the PRRS vaccine industry in China. There are 26 manufacturers of PRRS vaccines in China, including Dahuanong, Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Qingdao Yebio Bioengineering Co., Ltd. and Inner Mongolia Jinyu Group Stock Company. In terms of the direct sales of high-end vaccines, the PRRS vaccines of Zoetis went to the market in Guangzhou at the end of August 2013 after Boehringer. These foreign-funded vaccine brands occupy the market shares using the brand advantages, which intensify the market competition.

As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of PRRS vaccines will continue to increase in China in the next few years, which attract many animal health enterprises' attention.

Through this report, the readers can acquire the following information:
-Incidence Status of Porcine Reproductive and Respiratory Syndrome
-Status of China Breeding Industry
-Policy Environment and Government Procurement of PRRS Vaccines in China
-Supply and Demand Status of PRRS Vaccines in China
-Major Manufacturers of PRRS Vaccines and the Operation Status in China
-Prospect of China PRRS Vaccine Industry in China

The Following Enterprises and People Are Recommended to Purchase This Report:
-Manufacturers and Trading Enterprises of Animal Vaccines
-Breeding Enterprises
-Management Organizations of Livestock Industry
-Investors and Research Institutes Concerned about PRRS Vaccine Industry

Table of Contents
1 Status of Global and China PRRS Vaccine Market
1.1 Relevant Concepts of PRRS Vaccines
1.1.1 Definition of PRRS
1.1.2 Definition of PRRS Vaccine
1.2 Brief Introduction of Epidemic Situation of PRRS
1.2.1 Incidence Status of PRRS
1.2.2 Epidemic Situation of PRRS in China

2 Factors Influencing Development of PRRS Vaccines in China, 2009-2013
2.1 Policies in China Animal Vaccine Industry
2.1.1 Legislation of Animal Epidemic Prevention
2.1.2 Organization Structure
2.1.3 Appropriation Budget of Epidemic Prevention
2.1.4 Scope of Compulsory Immunization
2.1.5 Immunization Policies on Highly-pathogenic PRRS
2.2 Overview of Pig Breeding in China, 2009-2013
2.2.1 Livestock Volume of Pigs
2.2.2 Stock Volume of Fattened Pigs
2.2.3 Output Volume of Pork

3 Operation Status of PRRS Vaccine Industry in China, 2009-2013
3.1 Supply of PRRS Vaccines
3.1.1 Supply Overview
3.1.2 Factors Influencing Supply
3.2 Demand
3.2.1 Demand Overview
3.2.2 Factors Influencing Demand
3.3 Status of Free PRRS Vaccines Provided by the Government
3.3.1 Analysis of Existing Problems
3.3.2 Solutions to Problems

4 Major Manufacturers of PRRS Vaccines in China, 2011-2013
4.1 Guangdong Dahuanong Animal Health Products Co., Ltd.
4.1.1 Enterprise Profile
4.1.2 Production Status of PRRS Vaccines
4.1.3 Development Strategies of the Enterprise
4.2 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
4.2.1 Enterprise Profile
4.2.2 Production Status of PRRS Vaccines
4.2.3 Development Strategies
4.3 Qingdao Yebio Bioengineering Co., Ltd.
4.3.1 Enterprise Profile
4.3.2 Production Status of PRRS Vaccines
4.3.3 Development Strategies
4.4 Inner Mongolia Jinyu Group Stock Company
4.4.1 Enterprise Profile
4.4.2 Production Status of PRRS Vaccines
4.4.3 Development Strategies

5 Status of PRRS Vaccine Purchase in Some Local Governments in China, 2013
5.1 Bid Winning Status of PRRS Vaccines in Shandong, 2013
5.1.1 Bid Winning Enterprises and Products of PRRS Vaccines
5.1.2 Bid Winning Prices
5.2 Bid Winning Status of PRRS Vaccines in Shanxi, 2013
5.2.1 Bid Winning Enterprises and Products of PRRS Vaccines
5.2.2 Bid Winning Prices

6 Prospect of China PRRS Vaccine Industry, 2014-2018
6.1 Factors Influencing Development
6.1.1 Government Policies
6.1.2 Pig Breeding
6.2 Forecast on Supply and Demand
6.2.1 Forecast on Supply of PRRS Vaccines
6.2.2 Forecast on Demand for PRRS Vaccines

Selected Charts
Chart Epidemic Situation of PRRS in China, 2012-2014
Chart Expenses of Chinese Government on Animal Epidemic Prevention, 2009-2014
Chart Stock Volume of Fattened Pigs in China, 2009-2013
Chart Output Volume of Pork in China, 2009-2013
Chart Major Types of PRRS Vaccines in China
Chart Market Size of PRRS Vaccines in China, 2009-2013
Chart Forecast on Output Volume of PRRS Vaccines in China, 2014-2018
Chart Forecast on Market Size of PRRS Vaccines in China, 2014-2018

Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2017-2021

PRRS causes reproductive failure in breeding stock such as abortions and giving birth to stillborn, dyspnea in young pigs and sepsis. Mortality of sows and piglets of acute onset is above 40% while mortality of chronic onset is very low.

Scroll